From ₹9 Crore to ₹2.5 Lakh: Meet Dr. Sivaranjani Santosh, the Hyderabad Paediatrician Turning Medical Challenges into Hope for Seven Children

0
25

When a mother’s desperate appeal brought the unimaginable cost of a rare disease treatment into the spotlight, Hyderabad-based paediatrician Dr. Sivaranjani Santosh helped turn a seemingly impossible situation into a story of hope. Her efforts to make life-saving medication accessible to seven children with a rare genetic disorder demonstrate how medical knowledge, determination and collective action can change lives.

Dr. Sivaranjani Santosh

Sometimes, the most powerful stories in medicine are not about discovering a new drug or performing a complicated surgery. They are about making an existing treatment accessible to someone who desperately needs it.

For seven children in India diagnosed with Allan-Herndon-Dudley syndrome (AHDS), a rare genetic disorder, access to treatment seemed almost unimaginable. The medication, tiratricol, came with an estimated international treatment cost running into several crores of rupees annually. For families already navigating the emotional and financial challenges of raising children with a rare condition, the price was beyond reach.

But one mother’s appeal on social media helped bring attention to this extraordinary challenge. What followed was an encouraging example of medical advocacy, collaboration and determination.

At the centre of this effort was Hyderabad-based paediatrician Dr. Sivaranjani Santosh, who, alongside Access to Medicines India and international partners, helped facilitate a year’s supply of tiratricol for seven affected children. Through efforts to make the treatment available as a compounded formulation, the annual cost was brought down to approximately ₹2.5 lakh per child, compared with the previously reported multi-crore international cost.

The children are expected to receive a year’s supply free of cost, beginning November 30, 2026.

For these families, this is more than a medical development. It represents something that money cannot easily measure: hope.

A Doctor Who Believes Healthcare Must Go Beyond Prescriptions

With more than 18 years of experience in paediatrics, Dr. Sivaranjani Santosh has built her professional journey around a simple but important belief: children’s healthcare should focus not only on treating illness but also on preventing it.

An alumna of the prestigious Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, she completed both her MBBS and MD in Paediatrics from the institution.

Currently associated with Magna Centres for Obesity, Diabetes and Endocrinology at Film Nagar, Hyderabad, her clinical practice encompasses general paediatric care, newborn care, breastfeeding support, developmental concerns and preventive healthcare.

However, her contribution extends beyond the consultation room.

Through social media, public awareness campaigns, television discussions and newspaper articles, she has consistently worked to make reliable medical information accessible to parents. Her approach is rooted in challenging misinformation, questioning unsafe practices and encouraging families to make informed healthcare decisions.

The ORS Campaign: When Medical Science Meets Public Accountability

One of Dr. Sivaranjani’s notable public health advocacy efforts has been her campaign concerning Oral Rehydration Solution (ORS).

ORS is a critical intervention in managing dehydration, particularly among children suffering from diarrhoea. Its effectiveness depends on the correct balance of glucose and electrolytes, as established by the World Health Organization (WHO).

However, products marketed as ORS despite containing excessive sugar or failing to meet recommended standards became a subject of serious concern.

Dr. Sivaranjani repeatedly highlighted the difference between scientifically formulated ORS and sugary beverages being promoted using similar terminology.

Her campaign helped bring greater public attention to the issue, contributing to wider discussions around food labelling, consumer awareness and regulatory accountability. In October 2025, FSSAI issued a directive restricting the use of the term ORS for products that do not comply with prescribed standards.

The campaign demonstrated how a medical professional’s voice, when supported by scientific evidence and sustained public engagement, can contribute to meaningful changes in public health awareness and regulation.

Challenging Misinformation, One Parent at a Time

For many parents, navigating childhood illnesses can be overwhelming. Social media is filled with health advice, miracle remedies, nutritional products and recommendations that are not always supported by scientific evidence.

Dr. Sivaranjani has consistently used her public platform to address these concerns.

From questioning unnecessary nutritional supplements for children to discussing misleading food labels and promoting evidence-based paediatric practices, she encourages parents to distinguish between medical facts and marketing claims.

Her focus on preventive healthcare also includes newborn care, breastfeeding guidance, first aid and CPR awareness.

She believes that empowering parents with the right knowledge can prevent avoidable complications and help children receive timely care.

This commitment to public education has made her a familiar voice in discussions around child health and parenting.

More Than a Paediatrician: An Author, Educator and Award-Winning Professional

Dr. Sivaranjani’s professional journey also includes contributions to medical communication and education.

She authored the book Baby and Child Care, aimed at helping parents understand important aspects of raising healthy children and managing common childhood health concerns.

She has also written several articles on baby and child care for different publications and participated in television discussions addressing important issues concerning children’s health and well-being.

Her contributions received recognition when she was honoured with the Times of India Rising Star Award in Paediatrics in 2017.

These achievements reflect her interest in taking medical knowledge beyond hospital walls and making it understandable and useful for everyday families.

Seven Children, One Collective Effort and a Powerful Message

The tiratricol initiative brings together some of the most important aspects of Dr. Sivaranjani’s work: medical advocacy, collaboration, affordability and access to treatment.

Allan-Herndon-Dudley syndrome is an extremely rare genetic condition affecting thyroid hormone transport into the brain. It can cause severe neurological and developmental challenges, making early diagnosis and appropriate medical management particularly important.

For families dealing with such conditions, the challenges are enormous. Rare disease medicines may be difficult to source, treatment options may be limited, and costs can place an unbearable burden on households.

The effort to arrange treatment for these seven children illustrates why access to affordable medicines must be an important part of healthcare conversations.

The reduction in the reported annual treatment cost from several crores to approximately ₹2.5 lakh per child is particularly significant. Equally important is the arrangement for a year’s free supply, which offers families an opportunity to access treatment without bearing that immediate financial burden.

It is also a reminder that rare diseases should not mean that families are left without hope simply because treatment is expensive or difficult to obtain.

A Larger Vision for Healthcare

What makes Dr. Sivaranjani’s work noteworthy is the consistency of her advocacy across different areas of child health.

Whether highlighting the importance of scientifically correct ORS formulations, questioning misleading nutritional claims or helping bring affordable treatment within reach of children with a rare genetic condition, her efforts share a common purpose: putting children’s health and patient safety first.

Her journey reflects an important message for the medical community: the responsibility of a healthcare professional does not necessarily end when a consultation is over.

Sometimes, it means raising difficult questions. Sometimes, it means challenging established practices. And sometimes, it means bringing together people and organisations to solve a problem that individual families cannot overcome alone.

For the seven children awaiting access to tiratricol, this initiative represents a new chapter filled with possibility. For their parents, it is a reminder that their voices can be heard and that collective action can make a difference.

From educating parents to challenging misinformation and helping bridge the gap between expensive medical treatments and affordable access, Dr. Sivaranjani Santosh represents a growing and important dimension of modern healthcare: a doctor who not only treats children but also advocates for their right to better, safer and more accessible healthcare.

Because ultimately, the true measure of healthcare is not just how advanced a treatment is, but whether the people who need it can actually receive it.